A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Multi-Part, Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 13 Dec 2018
At a glance
- Drugs CK 274 (Primary)
- Indications Hypertrophic cardiomyopathy
- Focus Adverse reactions; First in man
- Sponsors Cytokinetics
- 05 Dec 2018 According to a Cytokinetics media release, first patient has been dosed in the trial.
- 05 Dec 2018 Status changed from planning to recruiting.
- 24 Oct 2018 New trial record